Cells, 2020 · DOI: 10.3390/cells9061420 · Published: June 8, 2020
Spinal cord injury (SCI) can lead to cognitive impairments and depression, affecting rehabilitation and quality of life. These changes are often overlooked clinically, but recent studies suggest a high risk of dementia in SCI patients. Clinical and experimental studies reveal complex brain responses following SCI, potentially due to neuroinflammation. Researchers are exploring therapeutic options to reduce brain neuroinflammation and improve cognitive and emotional outcomes after SCI. SCI can cause extensive long-term reorganization of the cerebral cortex and progressive reduction in grey matter volume in brain regions critical for emotional processing and attentional states. These widespread alterations may contribute to cognitive and mood disorders after SCI.
The review suggests potential therapeutic interventions, such as anti-depressants and targeting inflammation, to mitigate SCI-induced brain neuroinflammation and improve cognitive and emotional impairments.
The findings support the importance of clinical trials targeting inflammation to improve mood and neuropathic pain following SCI.
Future SCI rehabilitation efforts should better emphasize and examine the potential cognitive changes and mood disorders following SCI.